🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Tasocitinib 10 mg oral tablet

Found 27 matching trials

Pharmacokinetics Of CP-690,550 In Pediatric Patients With Juvenile Idiopathic Arthritis (JIA)

PHASE1

Phase 1 study to describe pharmacokinetics of CP-690,550 in pediatric patie...

Status

Completed

Location

Explorer Clinic, University of Minnesota Children's Hospital

Start Date

2013-03

Trial ID

NCT01513902

Treatments Being Tested

CP-690,550 CP-690,550 CP-690,550

Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTX

PHASE3

This study is designed to compare the effectiveness of the experimental dru...

Status

Completed

Location

Catalina Pointe Clinical Research, Inc.

Start Date

2010-01

Trial ID

NCT01039688

Treatments Being Tested

CP-690,550 CP-690,550 Disease-modifying antirheumatic drug

A Study To Estimate The Amount Of CP-690,550 (Study Drug) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of CP-690,550 In Tablet Form

PHASE1

In this study, a 10 mg dose of CP-690,550 will be given to study subjects o...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2010-07

Trial ID

NCT01143805

Treatments Being Tested

Tasocitinib 10 mg oral tablet Tasocitinib 10 mg IV Infusion

Study Of The Effects Of Atorvastatin On Cholesterol Levels In Rheumatoid Arthritis Patients Taking CP-690,550

PHASE2

All patients will be in instructed to eat a therapeutic lifestyle diet and ...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2010-02

Trial ID

NCT01059864

Treatments Being Tested

CP-690,550 Atorvastatin CP-690,550 Atorvastatin Placebo

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

PHASE4

The main aim of this study is to learn about the effect of treatment with v...

Status

Recruiting

Location

Digestive Health Specialsits

Start Date

2024-06-12

Trial ID

NCT06095128

Treatments Being Tested

Vedolizumab Tofacitinib

Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis

PHASE2

The purpose of this study is to determine the effectiveness and safety, ove...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2007-01

Trial ID

NCT00413660

Treatments Being Tested

CP-690,550 CP-690,550 CP-690,550 CP-690,550 CP-690,550 CP-690,550 placebo

Effect Of Ketoconazole On The Pharmacokinetics Of Tasocitinib (CP-690,550) In Healthy Volunteers

PHASE1

Estimate the effect of oral ketoconazole administration (400 mg once daily ...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2010-09

Trial ID

NCT01202240

Treatments Being Tested

Tasocitinib (CP-690,55) plus Ketoconazole

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

PHASE3

This study will test if CP-690,550 is safe and effective in rheumatoid arth...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-10

Trial ID

NCT00960440

Treatments Being Tested

CP-690,550 CP-690,550 Placebo CP-690,550 Placebo CP-690,550

A Study To Evaluate The Effect Of Food On How Tasocitinib (CP-690,550) Is Absorbed And Moves Through The Body Following Oral Administration Of Tasocitinib (CP-690,550) Tablets To Healthy Subjects

PHASE1

In this study, a 10 mg tasocitinib (CP-690,550) tablet will be administered...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2010-09

Trial ID

NCT01184001

Treatments Being Tested

Treatment A Treatment B Treatment B Treatment A

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

PHASE3

This is a comparative study of CP 690,550, Humira (adalimumab) and placebo ...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2009-05

Trial ID

NCT00853385

Treatments Being Tested

CP 690,550 CP-690,550 Placebo Placebo Biologic TNFi

Previous Next